Health Care
BioVeris CEO Samuel Wohlstadter was satisfied as well.
"We are pleased that this transaction will deliver substantial value to BioVeris shareholders," Wohlstadter said on Wednesday. "Given the history between the parties and the scope of Roche's existing diagnostics business, Roche is the natural buyer for BioVeris." Of course, Wohlstadter has never been one to walk away from his ventures completely. As part of the latest deal, he has formed two new entities that will retain BioVeris's vaccination business and continue to use the company's technology. Still, the 65-year-old Wohlstadter could retire in style if he wishes. He ranks as BioVeris's largest stockholder, with 1.9 million of the company's shares. He stands to pocket more than $40 million from his company's second sale.TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,393.45 | 1,310.33 | 2,827.34 | 15.81 |
Oil *
101.78
|
|
DOWN
26.41 |
DOWN
2.99 |
DOWN
10.02 |
DOWN
0.44 |
10 Yr
1.58%
SPDR Gold
151.62
|
|
-0.21%
|
-0.23%
|
-0.35%
|
-2.71%
|
Data delayed 20 minutes |
Connect with TheStreet